AD04 Trademark

Trademark Overview


On Wednesday, December 21, 2022, a trademark application was filed for AD04 with the United States Patent and Trademark Office. The USPTO has given the AD04 trademark a serial number of 79360473. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 14, 2024. This trademark is owned by ADvantage Therapeutics GmbH. The AD04 trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use

Providing medical information; providing health information

Research and development services and scientific advice in the field of pharmaceuticals and diagnostics; clinical research for others in the field of pharmaceuticals and diagnostics
ad04

General Information


Serial Number79360473
Word MarkAD04
Filing DateWednesday, December 21, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use
Pseudo MarkADVANTAGE ZERO FOUR
Goods and ServicesProviding medical information; providing health information
Goods and ServicesResearch and development services and scientific advice in the field of pharmaceuticals and diagnostics; clinical research for others in the field of pharmaceuticals and diagnostics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADvantage Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023NON-FINAL ACTION WRITTEN
Thursday, January 19, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023APPLICATION FILING RECEIPT MAILED
Friday, September 22, 2023ASSIGNED TO EXAMINER
Wednesday, October 18, 2023REFUSAL PROCESSED BY MPU
Wednesday, October 4, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 8, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 14, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 14, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 18, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 18, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 7, 2023REFUSAL PROCESSED BY IB
Monday, June 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB